REQORSA, consisting of the TUSC2 gene encapsulated in non-viral lipid nanoparticles, targets cancer cells specifically while minimizing uptake by normal tissue. This therapy is currently being ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Laurus aims to leverage India's manufacturing prowess to serve global cell and gene therapy players targeting the Indian ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

NOVEL lymph-node-inspired hydrogels enhance CAR T cell activation and proliferation by 50%, offering a more efficient and ...

The answer turned out to be a cutting-edge treatment that few Americans know about, according to Roswell Park Comprehensive ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Swim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, is proud to announce the award of two $450,000 grants to two of its beneficiaries ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

Roswell Park Comprehensive Cancer Center is at the forefront of a new approach to cancer treatment, called CAR T-cell therapy.